Juno Bio

London, United Kingdom Founded: 2018 • Age: 8 yrs
Microbiome-focused research services are provided by Juno Bio.

About Juno Bio

Juno Bio is a Healthcare company based in London (United Kingdom) founded in 2018 by Hana Janebdar. It operates as a microbiome-focused research services are provided by Juno Bio. Juno Bio has raised $3.8 million across 3 funding rounds from investors including Illumina, Pink Salt Ventures and AI Seed. The company has 5 employees. Its chief executive is Hana Janebdar. Its website juno.bio draws about 12 thousand monthly visits. Its focus areas include HealthTech, Healthcare Booking Platforms, Diagnostics and Internet First Clinical Labs. Its legal entity is JUNO BIO LIMITED. Its competitors include Atlas Biomed, OMED Health, Nylos and Biomesight.

Company details

Juno Bio was established in 2018 and is based in London, United Kingdom. Operations are centered in the biotechnology sector, with a focus on microbiome research. Services encompassing microbiome analysis and related scientific investigations are offered to support client needs. The company is led by Co-Founder and CEO Hana Janebdar, emphasizing factual advancements in microbial studies within a global context.

  • Headquarters London, United Kingdom
  • Employees 5
  • Founders Hana Janebdar
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website juno.bio
  • Social LinkedIn Facebook Instagram
  • Legal Name Juno Bio Limited
  • Date of Incorporation 11 Jun, 2018
  • Jurisdiction LONDON, UNITED KINGDOM
Key Metrics
  • Total Equity Funding
    $3.8M (USD)

    in 3 rounds

  • Latest Funding Round
    $3.8M (USD), Series A

    Jul 2026

  • Investors
    Illumina

    & 5 more

  • Employee Count
    5

Funding Insights of Juno Bio

Juno Bio has successfully raised a total of $3.8M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $3.8 million completed in July 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $3.8M
  • Total Rounds 3
  • Last Round Series A β€” $3.8M
  • Investors Count 6

All 3 funding rounds of Juno Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2026$3.8MSeries A––
Dec 2021–Seed––
Apr 2019–Seed––
Valuation history

6 investors in total: 6 institutional.

Investors in Juno Bio

Juno Bio has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Illumina, Pink Salt Ventures and AI Seed.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Early stage investments are provided to female-led technology companies.
–pinksaltventures.com-
AI Seed is recognized as a leading AI venture capital fund in Europe.
2017aiseedfund.comLondon, United Kingdom
-
–adaventures.com-
-
–artesianinvest.com-
-
–joinef.com-
Developer of technologies for analysis of genetic variation and function
1993illumina.comSan Diego, United States
Premium access

Investor details for Juno Bio

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Juno Bio

3 people are tracked at Juno Bio (3 in leadership); the tracked headcount is 5.

NameRoleGroup
Hana Janebdar
Co-Founder & CEOLeadership
Leighton Turner
CTO & co-FounderLeadership
Mario Hayashi
Head Of EngineeringLeadership
Premium access

Complete people profiles for Juno Bio

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Juno Bio

3 dated milestones of Juno Bio across 8 years, from founding to its latest funding, stage changes and deals.

  1. Founded Juno Bio is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Series A, of $3.8M.

Competitors of Juno Bio

Juno Bio has 4 listed competitors in our database. They include Atlas Biomed, OMED Health, Nylos and Biomesight, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
atlasbiomed.com2013London, United Kingdom–1
Genetic tests are offered via DNA and gut microbiome analysis.
omedhealth.com2022Cambridge, United Kingdom–199
Offers at-home breath testing and treatment for digestive health conditions.
nylos.me2019London, United Kingdom––
Offers online gut microbiome testing for personalized diet planning.
biomesight.com2019London, United Kingdom–4
Offers gut microbiome analysis, testing kits, and personalized supplement recommendations.
Premium access

Detailed competitors of Juno Bio

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Juno Bio

The website of Juno Bio (juno.bio) receives about 11.6K visits a month.

  • Monthly visits
    11.6K

    ▼ 18.7% vs previous month

Similar websites

Websites whose visitors overlap most with Juno Bio. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
usbiotek.com
100%
43.8K#667,914View details
microgendx.com
99%
90.1K#369,019View details
microbiomelabs.com
81%
54K#498,720View details

Top companies in Digital Health & Telemedicine

10 companies that operate in the same segment as Juno Bio (Digital Health & Telemedicine), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of an online pharmacy with doctor listing and teleconsultation services
2015Delhi, Delhi, IndiaUSD 230.8 MUSD 328.97 M5,212
Online platform offering multiple healthcare services
2013Bengaluru, Karnataka, IndiaUSD 199.22 MUSD 62.4 M52
An application is provided for comparing prescription drug prices nationwide.
2011Santa Monica, California, United StatesUSD 22.21 MUSD 796.85 M1,063
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
An online marketplace for healthcare products is operated.
2011Kolkata, West Bengal, IndiaUSD 38.26 M––
Alto Pharmacy is focused on providing convenient prescription delivery services.
2015San Francisco, California, United StatesUSD 591.64 M–802
Membership-based primary care platform is offered for employees and consumers.
2007San Francisco, California, United StatesUSD 402.56 M––
Telehealth solutions are provided for doctors and patients' consultations.
2006Boston, Massachusetts, United StatesUSD 887.35 MUSD 115.54 M742
Digital health services for men's wellness are offered by Ro.
2017New York, New York, United StatesUSD 1.03 B–1,485
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits
2006Sunnyvale, California, United StatesUSD 943.53 MUSD 189.9 M562
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Juno Bio

Premium access

Complete news archive for Juno Bio

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Juno Bio

Juno Bio was founded in 2018 and raised its 1st funding round 1 year after it was founded.

Juno Bio is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.

Hana Janebdar is the current CEO of Juno Bio. They have also founded this company.

Juno Bio is a funded company, having raised a total of $3.8M across 3 funding rounds to date.

Juno Bio has 5 employees.

Juno Bio was established in 2018 and is based in London, United Kingdom. Operations are centered in the biotechnology sector, with a focus on microbiome research. Services encompassing microbiome analysis and related scientific investigations are offered to support client needs. The company is led by Co-Founder and CEO Hana Janebdar, emphasizing factual advancements in microbial studies within a global context.

Juno Bio's top competitors include Atlas Biomed, OMED Health and Nylos.

Juno Bio has 6 investors. Key investors include Illumina, Pink Salt Ventures, AI Seed, Ada Ventures, and Artesian.

Juno Bio operates through Juno Bio Limited.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available